Gene Biotherapeutics, Inc. Operating Lease Liability
Gene Biotherapeutics, Inc. had Operating Lease Liability of $150.13 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2022-04-14
- 2020-12-31: Operating Lease, Liability $150.13K.
- 2020-09-30: Operating Lease, Liability $168.15K.
| Period end | Operating Lease, Liability |
|---|---|
| 2020-12-31 | $150.13K 10-K/A · filed 2022-04-14 |
| 2020-09-30 | $168.15K 10-Q · filed 2021-10-27 |